Imunon, Inc. (IMNN) Q1 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning. My name is Tina, and I will be your operator today. At this time, I would like to welcome everyone to the Immunion First Quarter 2026 Final Results Conference Call. All lines have been placed on mute to prevent any background noise. Following the speaker's remarks, there will be a question and answer session. You may press star 1 on your telephone keypad to ask a question at that time. Please keep in mind, if you are using a speakerphone, you must release your mute function to allow the signal to reach your equipment. Again, that is star one to ask your question during the Q&A session. I would now like to turn the call over to Brandon Weiner of ICR Health Services. care, investor relations, representatives of Immunion, please go ahead. Thank you. Good morning, everyone, and welcome to Immunion's first quarter 2026 financial results and business update conference call. During today's call, management will be making forward-looking statements regarding Immunion's expectations and projections about future events. In general, forward-looking statements can be identified by words such as expects, anticipates, believes, or other similar expressions. These statements are based on current expectations and are subject to a number of risks and uncertainties, including those set forth in the company's periodic filings with the Securities and Exchange Commission. No forward-looking statements can be guaranteed, and actual results may differ materially from such statements. I also caution that the content of this conference call is accurately as accurate only as of the date of the live broadcast, May 12th, 2026. Immunon undertakes no obligation to revise or update comments made during this call, except as required by law. With that said, I would like to turn the cal...